Nandu Nandkishore, Executive VP & Zone Director for Asia, Oceania & MidEast at Nestle, discusses the state of global food safety and outlines three solutions to combat recent food scares.» Read More
The food industry is facing a backlash against high sugar content on the same scale as the one experienced by the tobacco industry.
If the best time to buy is when there is bloodshed, then Pakistan's commercial capital offers the ideal investment opportunity. The NYT reports.
Chocoholics face higher prices for their sweet treats as candy makers deal with higher prices for cocoa butter.
Google, which is known for nick-naming its mobile operating systems after desserts, has for the first time chosen a brand-name candy for its 4.4 version that's expected to launch this fall.
L'Oreal's rumored buyback of Nestle's 29.5 percent stake in the French cosmetics giant looked far from a done deal on Friday, with Jean-Paul Agon, chairman and CEO of L'Oreal, telling CNBC that the ball was in the Swiss food giant's court.
Jean-Paul Agon, chairman & CEO of L'Oréal, tells CNBC that it's not their decision whether to buy the Nestle stake in L'Oréal as Nestle must decide if it wants to sell it.
Nestlé and Unilever will soon be able to see what’s going on in any tropical forests in real-time, down to 1 meter. Is this the "good side" of the surveillance state?
The global coffee market has been rather decaffeinated for the past couple of years, with prices falling to less than half their 2011 peak and the bean becoming the worst-performing soft commodity last year.
European shares closed higher on Thursday following better-than-expected trade numbers from China, signaling tentative signs of an economic recovery.
Underlying sales at Nestle grew 4.1 percent in the first half, missing forecasts and lagging growth of rivals Danone and Unilever, as price erosion continued in Europe.
Jon Cox, head of Swiss research at Kepler Cheuvreux, tells CNBC that the problem for Nestle is the deceleration in emerging markets.
China fined six companies including New Zealand dairy giant Fonterra a total of $110 million following an investigation into price fixing and anti-competitive practices by foreign baby formula makers.
New Zealand's Fonterra said it had found that an ingredient in its dairy products that contained a strain of a bacteria which can cause botulism, prompting China to recall affected products.
Pfizer reported earnings slightly ahead of forecasts, as the largest U.S. drugmaker lines up a business split that could lead to the spin-off of its generics division.
Mark Howden, managing director at Nomura, explains why his "long term love affair" with consumer staples remains intact and why he is bearish on Nestle in the short term.
China is using "concerted" probes of foreign baby formula, pharmaceutical and packaging companies to bolster domestic firms, according to observers.
Chinese authorities are investigating a possible price-fixing for infant formula milk, as consumers pay premiums for imported products on fears that local ones may be contaminated.
European shares were higher in early afternoon trade on Wednesday despite preliminary growth data from the euro zone missing estimates.
Family-run firms are shaking up the consumer deals market, squeezing out private-equity firms and forcing them to change strategy.
Slower economic growth is dulling the outlook for equities, but consumer sector stays appealing in the long term.